Back
 Health  Vol.8 No.13 , October 2016
The Role of Atherosclerosis and Inflammation in the Development of Descending Aortic Aneurysms: Special Aspects of Medical Correction
Abstract: Modern medicine has achieved much progress in the field of medical and surgical repair of a variety of disorders. It is especially true for the early stages of treatments. In long-term period, however, instead of recovery, we frequently observe progressive regression, which completely annuls all our efforts. Moreover, the algorithm used to correct acute process may sometimes be detrimental to organs and tissues. Such situation is also frequent in the treatment of atherosclerotic descending aortic aneurysms (DAA). This is because the successful medical and even surgical repair to prevent aneurysm rupture in long-term period may trigger some detrimental processes in other regions thus producing negative results of the treatment. The present article doesn’t aim to prove some provisions in DAA clinical picture, atherosclerosis and inflammatory states. But we have faced some systematicity at these clinical implications which are absolutely not specified in literature. We have managed to find an explanation for this thing making a scrupulous analysis of nonsurgical sources. Comparing them with our observations, we have found out that aseptic and septic inflammation of connective tissue, probably, is a key component in the formation of DAA disregarding of which correction of dyslipidemia may lead to negative results. We are looking for in-depth research and discussion.
Cite this paper: Krylov, V. , Mana, N. , Titov, L. , Gayduk, V. , Reut, L. , Mankevich, N. , Zhigalcovitch, A. , Smolyakou, A. , Popel, G. and Pyzhyk, R. (2016) The Role of Atherosclerosis and Inflammation in the Development of Descending Aortic Aneurysms: Special Aspects of Medical Correction. Health, 8, 1335-1348. doi: 10.4236/health.2016.813134.
References

[1]   Tsao, P. and Burasor, I. (2011) The Need for Novel Biomarkers of Abdominal Aortic Aneurysm Disease. Scientific Journal of the Faculty of Medicine in Nis, 28, 119-124.

[2]   Eberhardt, R.T. and Coffman, J.D. (2004) Cardiovascular Morbidity and Mortality in Peripheral Arterial Disease. Current Drug Targets: Cardiovascular & Hematological Disorders, 4, 209-217.

[3]   Aggarwal, A., Qamar, V. and Sharma, A. (2011) Abdominal Aortic Aneurysm: A Comprehensive Review. Experimental & Clinical Cardiology, 16, 11-15.

[4]   Juraszek, A., Bayer, G., Dziodzio, T., Kral, A., Laufer, G. and Ehrlich, M. (2013) Evaluation of the Intraoperative Specimens of the Thoracic and Ab-dominal Aorta. Journal of Cardiothoracic Surgery, 8, 110.
http://dx.doi.org/10.1186/1749-8090-8-110

[5]   Fishbein, G.A. and Fishbein, M.C. (2009) Arteriosclerosis: Rethinking the Current Classification. Archives of Pathology & Laboratory Medicine, 133, 1309-1316.

[6]   Novikova, E.G., Titova, G.P. and Galankina, I.E. (2013) Morphological Changes in Aortic Wall in Dissecting Aneurysm. Arkhiv Patologii, 6, 3-8.

[7]   Novikova, E.G. and Galankina, I.E. (2012) Anatomico-Pathological Criteria of Dissecting Aortic Aneurysm. Arkhiv Patologii, 5, 12-17.

[8]   Nikonenko, А.А. and Trilin, А.V. (2013) The Role of Cyclosporine A in Pathogenesis of Abdominal Aortic Aneurysm. Cardiologia i Serdechnososudistaya Khirurgiya, 6, 39-42.

[9]   Kemma, А., John, Thomas, L.F. and Serrius Patrick, V. (2011) Cardiovascular Disease Edition. “ESC Guidelines” GEOTAR-Media, 1209-1248. (In Russian)

[10]   Tsaregorodtsev, А.G. (2009) Dysplasia of Connective Tissue: Vascular Impairments. Causes for Sudden Death. Sibirsk Medical Journal, 1, 34-39.

[11]   Gens, А.P. (2004) Surgical Treatment of Aortic Aneurysm due to Connective Tissue Dysplasia. RAMN, Russian Research Centre of Surgery, Moscow, 37.

[12]   Leiva, M.S. and Fish, S.A. (1992) Leucocyte Chemoatractive Activity of Cyclophilin. Journal of Biological Chemistry, 267, 1168-1171.

[13]   Neal, L. (2009) Weintraub Understanding Abdominal Aortic Aneurysm. The New England Journal of Medicine, 10, 11.

[14]   Сapri, M., Salvioli, S., Sevini, F., et al. (2006) The Genetics of Humanlongevity. Annals of the New York Academy of Sciences, 1067, 252-263.
http://dx.doi.org/10.1196/annals.1354.033

[15]   Wang, M., Zhang, J., Spinetti, G., et al. (2005) Angiotensin 11 Activates Matrix Metalloproteinase Type 11 and Mimics Age-Associated Carotid Arterial Remodeling in Young Rats. American Journal of Pathology, 167, 1429-1442.
http://dx.doi.org/10.1016/S0002-9440(10)61229-1

[16]   Venugopal, S.K., Devaraj, S., Yuhanna, I., Shaul, P. and Jialal, I. (2002) Demonstration That C-Reactiive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells. Circulation, 106, 1439-1441.
http://dx.doi.org/10.1161/01.CIR.0000033116.22237.F9

[17]   Wang, M., Zhang, J., Jiang, L.Q., et al. (2007) Proinflammatory Profile within the Grosly Normal Aged Human Aortic Wall. Hypertension, 50, 219-227.
http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.089409

[18]   Lim, M.A. (2009) Arterial Compliance in the Elderly: Its Effect on Blood Pressure Measurement and Cardiovascular Outcomes. Clinics in Geriatric Medicine, 25, 191-205.
http://dx.doi.org/10.1016/j.cger.2009.01.001

[19]   Gayduk, V.N., Krylov, V.P., Reut, L.I., Smolyakov, А.L. and Mankevich, N.V. (2014) Management Optimization for Patients with Chronic Atherosclerotic Aneurysm of Descending Aorta. Meditsina, 3, 20-26.

[20]   Mankevich, N.V., Mrochek, А.G., Krylov, V.P., Gayduk, V.N., Reut, L.I. and Smolyakov, А.L. (2015) Predictors of the Progression of Atherosclerotic Aneurysms of Descending Aorta and Repair. Kardiologiya v Belarusi, 5, 63-73.

[21]   Krylov, V.P., Mrochek, A.G., Gaiduk, V.N., Reut, L.I., Smaliakou, A.L., Mankevich, N.V. and Pizhik, R.N. (2016) A Five-Year Experience of Sparing Treatment of Descending Aortic Atherosclerotic Aneurysms. World Journal of Cardiovascular Surgery, 6, 47-54.
http://dx.doi.org/10.4236/wjcs.2016.64009

[22]   Patel, P., Carington, D., Strachan, D.P., Leatham, E., Goggin, P., Nitrfield, T.C. and Mendall, M.A. (1994) Fibrinogen: A Link between Chronic Infection and Coronary Heart Disease. Lancet, 343, 1634-1635.
http://dx.doi.org/10.1016/S0140-6736(94)93084-8

[23]   Titov, V.N. (1998) Patherosclerosis Pathogenesis for 21th Century. Clinical Laboratory Diagnosis, 3-11.

[24]   Titov, V.N. (1999) The Relationship between Atherosclerosis and Inflammation: Specificity of Atherosclerosis as an Inflammatory Process. Rossiyskiy kardiologicheski zhurnal, 5, 1-15.

[25]   Steel, D.M. and Wikithead, A.S. (1991) The Major Acute Phase Reactants C-Reactive Protein, Serum Amyloid F Component and Serum Amyloid A Protein. Immunology Today, 15, 81-88.
http://dx.doi.org/10.1016/0167-5699(94)90138-4

[26]   Berliner, J.A., Navab, M., Fogelman, A.M., Frank, J.S., Demer, L.L., Edwards, P.A., Watson, A.D. and Lusis, A.J. (1995) Athero-sclerosis: Basic Mechanism Oxidation, Inflammation, and Genetic. Circulation, 91, 2488-2496.
http://dx.doi.org/10.1161/01.CIR.91.9.2488

[27]   Jialall, D.R. (1996) Low Density Lipo-protein Oxidation? Antioxidants and Atherosclerosis: A Clinical Biochemical Perspective. Clinical Chemistry, 42, 498-506.

[28]   Johnson, P.V. (1985) Dietary Fat, Eicosanoids and Immunity. Advances in Lipid Research, 4, 103-141.
http://dx.doi.org/10.1016/B978-0-12-024921-3.50010-1

[29]   Schmidt, M.L.H., Ford-Hunchinen, A.W. and Bray, M.A. (1980) Leucotriene B: A Potential Mediator of the Inflammation. Journal of Pharmacy and Pharmacology, 32, 517-518.
http://dx.doi.org/10.1111/j.2042-7158.1980.tb12985.x

[30]   Belova, L.А. (1997) Biochemistry of Inflammatory Processes and Vascular Damage. The Role of Neutrophils. Biokhimia, 62, 659-668.

[31]   Martinov, А.I., Gudilin, А., Drokina, О.V., Kalinina, I.Y., Nechaeva, G.I. and Tsikunova, Y.S. (2015) Endothelial Dysfunction in Patients with Connective Disuse Dysplasia. Lechaschiy Vrach, 2, 18-21.

[32]   Prophylaxis and Control of Noninfectious Diseases and Injuries in the Russian Federation (Project) (2008) Profilaktika zabolevaniy I ukreplenie zdorovya, 9-19.

[33]   Kukhartchuk, V.V. (1996) Treatment of Atherosclerosis. Terapevticheski? Arkhiv, 5-8.

[34]   Tvorogova, М.G., Vasin, P.N., Rozhkova, Т.А., Kukharchuk, V.V. and Titov, V.N. (1998) Lipid Composition of High-Density Lipoproteins in Inherited Hyperlipoproteinemias. Issues of Medical Chemistry, 44, 452-459.

[35]   Biasi, F., Ranzi, M.L., Erba, M., Tarsia, P., Raccaneli, P., Fagetti, L. and Alegra, L. (1996) No Evidence for the Presence Helicobacter Pylori in Atherosclerotic Plaques in Abdominal Aorta Aneurysm Specimens. Atherosclerosis, 126, 339-340.

[36]   Clifton, P.M., Mackinnon, A.M. and Barter, P.J. (1985) Effect of Serum Amyloid A Protein (SAA) on Composition Size and Density of High Density Lipoprotein in Subjects with Myocardial Infarction. Lipid Research, 26, 1389-1398.

[37]   Danesh, J., Collins, R. and Peto, R. (1997) Chronic Infection and Coronary Heart Disease. Is there a link? Lancet, 350, 430-436.
http://dx.doi.org/10.1016/S0140-6736(97)03079-1

[38]   Folsom, A.R., Nieto, J., Sorlie, P., Chambles, E. and Gracham, D.Y. (1998) Helibacteria Pylori Seropositivity and Coronary Heart Disease Incidence. Circulation, 98, 845-850.
http://dx.doi.org/10.1161/01.CIR.98.9.845

[39]   Fuster, V., Badimon, J.J. and Cjesebro, J.H. (1992) The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndrome. New England Journal of Medicine, 326, 242- 250.
>http://dx.doi.org/10.1056/NEJM199201233260406

[40]   Fyfe, A.I., Rothenberg, L.S., de Beer, F.C., Cantor, R.M. and Ritten, J.I. (1997) Association between Serum Amyloid a Proteins and Coronary Artery Disease. Evidence from Two Distinct Arteriosclerotic Processes. Circulation, 96, 2914-2919.
http://dx.doi.org/10.1161/01.CIR.96.9.2914

[41]   Netchaeva, G.I. and Viktoriva, I.А. (2007) Connective Tissue Dysplasia: Terms, Diagnosis, Management. Blankom, Omsk, 188.

[42]   Konev, V.P. (2011) Morphological Phenomena for Sectional Diagnosis of Connective Tissue Dysplasia: Review. Sibirsky Meditsinski Zhurnal, 3, 19-22.

[43]   Strazhesko, I.D., Akasheva, D.U., Dudinskaya, Е.N., Kruglikova, А.S., Tkacheva, V.S. and Pikhtina, V.S. (2013) Renin-Angiotensin-Aldosterone System and Vascular Ageing. Kardiologiya, 7, 78-84.

[44]   Osipov, S.G. and Titov V.N. (1982) Immune Complexes and Atherosclerosis. Kardiologiya, 119-125.

[45]   Chui, В., Vira, E., Tucker, W. and Fong, I.W. (1997) Chlamidiapneumoniae, Cytomegaloviruses and Herpes Simplex Virus in Atherosclerosis of the Carotid Artery. Circulation, 96, 2144-2148.
http://dx.doi.org/10.1161/01.CIR.96.7.2144

[46]   Santhanam, L. (2008) Arginase and Vasrular Aging. Journal of Applied Physiology, 105, 1632-1642.
http://dx.doi.org/10.1152/japplphysiol.90627.2008

[47]   Ryabov, G.A. and Azizov, Y.М. (2001) The Role of Nitric Oxide in the Regulation of Cell Processes in the Development of Polyorgan Failure. Anesteziologiya i Reanimatologiya, 1, 8-13.

[48]   Drokina, О.V. (2014) Clinical Significance of the Assessment of Arterial Stiffness and Endothelial Vasomotor Function in the Settings of Connective Tissue Dysplasia. MD Thesis, State Educational Institution of Higher Professional Education, Barnaul, 23.

[49]   Polevshikov, А.V., Nazarov, P.G., Kozlov, S.V., Galkina, Е.V. and Berestovaya, L.K. (1996) Regulation of Blood Neutrophil Function by Serum Amyolid P and С-Reactive Protein. Sibirsky Meditsinski Zhurnal, 84, 67-72.

[50]   Krylov, V.P., Titov, L.P., Gayduk, V.N., Reut, L.I., Smаliakou, A.L. and Mankevich, N.V. (2015) Atherosclerotic Descending Aortic Aneurysm. World Journal of Cardiovascular Surgery, 5, 91-101.
http://dx.doi.org/10.4236/wjcs.2015.59015

[51]   EVAR Trial Participants (2005) Endovascular Aneurysm Repair versus Open Repair in Patients with Abdominal Aortic Aneurysm (EVAR Trial 1): Randomised Controlled Trial. Lancet, 365, 2179-2186.
http://dx.doi.org/10.1016/S0140-6736(05)66627-5

[52]   EVAR Trial Participants (2005) Endovascular Aneurysm Repair and Outcome in Patients Unfit for Open Repair of Abdominal Aortic Aneurysm (EVAR Trial 2): Randomised Controlled Trial. Lancet, 365, 2187-2192.
http://dx.doi.org/10.1016/S0140-6736(05)66628-7

[53]   Gu, L., Johnson, M.W. and Lusis, A.J. (1999) Quantitative Trail Locus Analysis of Plasma Lipoprotein Levels in an Autoimmmune Mouse Model. Interaction between Lipoprotein Metabolism, Autoimmune Disease and Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 442-453.
http://dx.doi.org/10.1161/01.ATV.19.2.442

[54]   Seco, Y., Sato, O., Takagi, A., Tada, Y., Matsuo, H., Yaguta, H., Okumura, M. and Yazaki, Y. (1996) Restricted Usage of T-Cell Receptor Vα-Vβ Genes in Infiltrating Cells in Aorta Tissue of Patients with Takayasus Arteritis. Circulation, 93, 1788-1790.
http://dx.doi.org/10.1161/01.CIR.93.10.1788

[55]   Krylov, V.P., Mrochek A.G., Titov, L.P., Gaiduk, V.N., Reut, L.I. and Smaliakou, A.L. (2014) Can We Change a Look at Atherosclerotic Aortic Aneurism Treatment? Health, 6, 1345-1351.
http://dx.doi.org/10.4236/health.2014.612165

 
 
Top